Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Steroid for Basal Joint Arthritis
NCT01045694Phase 4Terminated
- Sponsor
- University of Missouri
- Start
- Mar 2011
- Primary completion
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in carpometacarpal osteoarthritis, sponsored by University of Missouri. Started Mar 2011; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
carpometacarpal osteoarthritis
Beyond the preview
Go deeper on NCT01045694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045694.